270 related articles for article (PubMed ID: 15364407)
1. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.
Fu AL; Li Q; Dong ZH; Huang SJ; Wang YX; Sun MJ
Neurosci Lett; 2004 Sep; 368(3):258-62. PubMed ID: 15364407
[TBL] [Abstract][Full Text] [Related]
2. Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease.
Feng Z; Chang Y; Cheng Y; Zhang BL; Qu ZW; Qin C; Zhang JT
J Pineal Res; 2004 Sep; 37(2):129-36. PubMed ID: 15298672
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
Bird TD; Stranahan S; Sumi SM; Raskind M
Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
[TBL] [Abstract][Full Text] [Related]
4. Transducible P11-CNTF rescues the learning and memory impairments induced by amyloid-beta peptide in mice.
Qu HY; Zhang T; Li XL; Zhou JP; Zhao BQ; Li Q; Sun MJ
Eur J Pharmacol; 2008 Oct; 594(1-3):93-100. PubMed ID: 18644361
[TBL] [Abstract][Full Text] [Related]
5. Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type.
Ishrat T; Parveen K; Khan MM; Khuwaja G; Khan MB; Yousuf S; Ahmad A; Shrivastav P; Islam F
Brain Res; 2009 Jul; 1281():117-27. PubMed ID: 19374888
[TBL] [Abstract][Full Text] [Related]
6. Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil.
Luques L; Shoham S; Weinstock M
Exp Neurol; 2007 Aug; 206(2):209-19. PubMed ID: 17580085
[TBL] [Abstract][Full Text] [Related]
7. [Experimental techniques for developing new drugs acting on dementia (10)--Alzheimer's disease animal model induced by beta-amyloid protein].
Nitta A; Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Jun; 16(3):85-90. PubMed ID: 8905795
[TBL] [Abstract][Full Text] [Related]
8. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease.
Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN
Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900
[TBL] [Abstract][Full Text] [Related]
9. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
Hernandez CM; Terry AV
Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
[TBL] [Abstract][Full Text] [Related]
10. [Trial to produce animal model of Alzheimer's disease by continuous infusion of beta-amyloid protein into the rat cerebral ventricle].
Nabeshima T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Oct; 15(5):411-8. PubMed ID: 8564734
[TBL] [Abstract][Full Text] [Related]
11. Implanted cannula-mediated repetitive administration of Abeta25-35 into the mouse cerebral ventricle effectively impairs spatial working memory.
Yamada M; Chiba T; Sasabe J; Nawa M; Tajima H; Niikura T; Terashita K; Aiso S; Kita Y; Matsuoka M; Nishimoto I
Behav Brain Res; 2005 Nov; 164(2):139-46. PubMed ID: 16122819
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of melatonin or 17 beta-estradiol on improving spatial memory performance in cognitively impaired, ovariectomized adult rats.
Feng Z; Cheng Y; Zhang JT
J Pineal Res; 2004 Oct; 37(3):198-206. PubMed ID: 15357665
[TBL] [Abstract][Full Text] [Related]
13. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer's disease rat model.
Wu QY; Li J; Feng ZT; Wang TH
Neurosci Lett; 2007 May; 417(3):281-5. PubMed ID: 17412501
[TBL] [Abstract][Full Text] [Related]
15. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of TAT-haFGF(₁₄₋₁₅₄) attenuates disease progression in a mouse model of Alzheimer's disease.
Lou G; Zhang Q; Xiao F; Xiang Q; Su Z; Zhang L; Yang P; Yang Y; Zheng Q; Huang Y
Neuroscience; 2012 Oct; 223():225-37. PubMed ID: 22885230
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT).
Ishrat T; Hoda MN; Khan MB; Yousuf S; Ahmad M; Khan MM; Ahmad A; Islam F
Eur Neuropsychopharmacol; 2009 Sep; 19(9):636-47. PubMed ID: 19329286
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice.
Fu AL; Dong ZH; Sun MJ
Brain Res; 2006 Sep; 1109(1):201-6. PubMed ID: 16872586
[TBL] [Abstract][Full Text] [Related]
19. Complementary remedy of aged-related learning and memory deficits via exogenous choline acetyltransferase.
Fu AL; Huang SJ; Sun MJ
Biochem Biophys Res Commun; 2005 Oct; 336(1):268-73. PubMed ID: 16126175
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human NGF-loaded microspheres promote survival of basal forebrain cholinergic neurons and improve memory impairments of spatial learning in the rat model of Alzheimer's disease with fimbria-fornix lesion.
Gu H; Long D; Song C; Li X
Neurosci Lett; 2009 Apr; 453(3):204-9. PubMed ID: 19429036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
